dihydrohonokiol-B (BETR-002) / BetterLife Pharma - LARVOL DELTA

BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety (GlobeNewswire) - "BetterLife Pharma Inc...is pleased to announce funding of its joint application with Dr. Argel Aguilar-Valles at Carleton University ('Carleton') Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression....As part of the research agreement, Dr. Argel Aguilar-Valles’s team will work with BetterLife to test TD-010 in both in vitro and in vivo models that are established in their lab."

Financing • Preclinical • CNS Disorders • Depression • Major Depressive Disorder